United States · 
What does Asymmetry Ventures invest in?
Asymmetry Ventures invests most often at Seed and Venture (78% of the rounds on record), in sectors such as AI & Machine Learning, Advanced Materials and Apps.
Asymmetry Ventures highlights
- 01
3 cheques in the last 12 months
- 02
Mostly Seed and Venture: 78% of its rounds
- 03
Sole investor in 4 rounds, median $3.5M
What they do
AV is honored to be selected by Business Insider to its “Seed 100” rankings of the world’s top early-stage investors!From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $125K – $500K as they say
- Stages
- Pre-seedSeedSeries ASeries BGrowth
- Sectors
- AI & Machine LearningAdvanced MaterialsApps
- Based in
- San Francisco, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first55 appearances
- 2026
2 rounds
- Jul
- Feb
- 2025
8 rounds
- Dec
- Oct
- Oct
- Sept
- Aug
- May
- Mar
- Feb
- 2024
8 rounds
- Nov
- Aug
- Jul
- JulCytoReasonSeries B · IL$80MWith 2 others
- May
- Apr
- Mar
- Jan
- 2023
14 rounds
- Dec
- Nov
- Nov
- Nov
- Sept
- Aug
- Aug
- Aug
- Jun
- Apr
- Apr
- Apr
- Apr
- Mar
- 2022
10 rounds
- Nov
- Nov
- Nov
- Nov
- May
- Apr
- Mar
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration1 named
RNRob NessExecutive OfficeriFiling they signed
We also hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What they claim to have backed
From their own portfolio page (on their website)
11 of 23 we have independently watched raise
BilliontooneFrontierBioGenecisHypointInpharmdMastreforestNewcultureOrbitfabSpace infrastructure technologyStatiqTybrhealthAccelerating Quantum AdvantageAdvanced isotope production technologyCoreshellCostplusdrugsCyberdonticsCytoreasonForesightmentalhealthJunokidsKernalbioPlay games, win cashRejuvenationtechSynovalife
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.